@article {967,
	title = {Importance of Optimal Dosing ? 30 mg/kg/d During Deferasirox Treatment: 2},
	journal = {European Journal of Haematology},
	year = {2011},
	note = {n/a},
	abstract = {<p>Following 1-yr deferasirox therapy in the ESCALATOR study, 57\% of previously chelated patients with ?-thalassaemia achieved treatment success (maintenance of or reduction in liver iron concentration (LIC) vs. baseline LIC). Seventy-eight per cent had dose increases at median of 26 wk,</p>
},
	author = {Ali Taher and Mohsen S. Elalfy and Kusai Al Zir and Shahina Daar and Abdullah Al Jefri and Dany Habr and Ulrike Kriemler-Krahn and Ali El-Ali and Bernard Roubert and Amal El-Beshlawy}
}
